Skip to menu Skip to content Skip to footer

2019

Journal Article

Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease

Paz, Katelyn, Flynn, Ryan, Du, Jing, Qi, Jun, Luznik, Leo, Maillard, Ivan, MacDonald, Kelli P., Hill, Geoffrey R., Serody, Jonathan S., Murphy, William J., Sage, Peter T., Sharpe, Arlene H., Miklos, David, Cutler, Corey S., Koreth, John, Antin, Joseph H., Soiffer, Robert J., Ritz, Jerome, Bradner, James E., Melnick, Ari M. and Blazar, Bruce R. (2019). Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease. Blood, 133 (1), 94-99. doi: 10.1182/blood-2018-03-839993

Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease

2019

Journal Article

Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease

Paz, Katelyn, Flynn, Ryan, Du, Jing, Tannheimer, Stacey, Johnson, Amy J., Dong, Shuai, Stark, Anne-Katrien, Okkenhaug, Klaus, Panoskaltsis-Mortari, Angela, Sage, Peter T., Sharpe, Arlene H., Luznik, Leo, Ritz, Jerome, Soiffer, Robert J., Cutler, Corey S., Koreth, John, Antin, Joseph H., Miklos, David B., MacDonald, Kelli P., Hill, Geoffrey R., Maillard, Ivan, Serody, Jonathan S., Murphy, William J., Munn, David H., Feser, Colby, Zaiken, Michael, Vanhaesebroeck, Bart, Turka, Laurence A., Byrd, John C. and Blazar, Bruce R. (2019). Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease. American Journal of Transplantation, 19 (6) ajt.15305, 1820-1830. doi: 10.1111/ajt.15305

Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease

2018

Journal Article

Distinct roles for CD4+ Foxp3+ regulatory T cells and IL-10–mediated immunoregulatory mechanisms during experimental visceral Leishmaniasis caused by Leishmania donovani

Bunn, Patrick T., Montes de Oca, Marcela, de Labastida Rivera, Fabian, Kumar, Rajiv, Ng, Susanna S., Edwards, Chelsea L., Faleiro, Rebecca J., Sheel, Meru, Amante, Fiona H., Frame, Teija C. M., Muller, Werner, Haque, Ashraful, Uzonna, Jude E., Hill, Geoffrey R. and Engwerda, Christian R. (2018). Distinct roles for CD4+ Foxp3+ regulatory T cells and IL-10–mediated immunoregulatory mechanisms during experimental visceral Leishmaniasis caused by Leishmania donovani. The Journal of Immunology, 201 (11), 3362-3372. doi: 10.4049/jimmunol.1701582

Distinct roles for CD4+ Foxp3+ regulatory T cells and IL-10–mediated immunoregulatory mechanisms during experimental visceral Leishmaniasis caused by Leishmania donovani

2018

Journal Article

Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation

Jacquelin, Sebastien, Straube, Jasmin, Cooper, Leanne, Vu, Therese, Song, Axia, Bywater, Megan, Baxter, Eva, Heidecker, Matthew, Wackrow, Brad, Porter, Amy, Ling, Victoria, Green, Joanne, Austin, Rebecca, Kazakoff, Stephen, Waddell, Nicola, Hesson, Luke B., Pimanda, John E., Stegelmann, Frank, Bullinger, Lars, Döhner, Konstanze, Rampal, Raajit K., Heckl, Dirk, Hill, Geoffrey R. and Lane, Steven W. (2018). Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation. Blood, 132 (26), blood-2018. doi: 10.1182/blood-2018-04-846220

Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation

2018

Journal Article

Myeloma escape after stem cell transplantation is a consequence of t-cell exhaustion and is prevented by tigit blockade

Minnie, Simone A., Kuns, Rachel D., Gartlan, Kate H., Zhang, Ping, Wilkinson, Andrew N., Samson, Luke, Guillerey, Camille, Engwerda, Christian, MacDonald, Kelli P. A., Smyth, Mark J., Markey, Kate A., Vuckovic, Slavica and Hill, Geoffrey R. (2018). Myeloma escape after stem cell transplantation is a consequence of t-cell exhaustion and is prevented by tigit blockade. Blood, 132 (16), 1675-1688. doi: 10.1182/blood-2018-01-825240

Myeloma escape after stem cell transplantation is a consequence of t-cell exhaustion and is prevented by tigit blockade

2018

Journal Article

Bone marrow transplantation generates T cell–dependent control of myeloma in mice

Vuckovic, Slavica, Minnie, Simone A., Smith, David, Gartlan, Kate H., Watkins, Thomas S., Markey, Kate A., Mukhopadhyay, Pamela, Guillerey, Camille, Kuns, Rachel D., Locke, Kelly R., Pritchard, Antonia L., Johansson, Peter A., Varelias, Antiopi, Zhang, Ping, Huntington, Nicholas D., Waddell, Nicola, Chesi, Marta, Miles, John J., Smyth, Mark J. and Hill, Geoffrey R. (2018). Bone marrow transplantation generates T cell–dependent control of myeloma in mice. Journal of Clinical Investigation, 129 (1) CI98888, 106-121. doi: 10.1172/jci98888

Bone marrow transplantation generates T cell–dependent control of myeloma in mice

2018

Journal Article

TIGIT immune checkpoint blockade restores CD8 T cell immunity against multiple myeloma

Guillerey, Camille, Harjunpää, Heidi, Carrié, Nadège, Kassem, Sahar, Teo, Tricia, Miles, Kim, Krumeich, Sophie, Weulersse, Marianne, Cuisinier, Marine, Stannard, Kimberley, Yu, Yuan, Minnie, Simone A., Hill, Geoffrey R., Dougall, William C., Avet-Loiseau, Hervé, Teng, Michele W. L., Nakamura, Kyohei, Martinet, Ludovic and Smyth, Mark J. (2018). TIGIT immune checkpoint blockade restores CD8 T cell immunity against multiple myeloma. Blood, 132 (16), blood-2018. doi: 10.1182/blood-2018-01-825265

TIGIT immune checkpoint blockade restores CD8 T cell immunity against multiple myeloma

2018

Journal Article

Immune regulatory cell infusion for graft-versus-host disease prevention and therapy

Blazar, Bruce R., MacDonald, Kelli P.A. and Hill, Geoffrey R. (2018). Immune regulatory cell infusion for graft-versus-host disease prevention and therapy. Blood, 131 (24), 2651-2660. doi: 10.1182/blood-2017-11-785865

Immune regulatory cell infusion for graft-versus-host disease prevention and therapy

2018

Journal Article

Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease

Takahashi, Shuichiro, Hashimoto, Daigo, Hayase, Eiko, Ogasawara, Reiki, Ohigashi, Hiroyuki, Ara, Takahide, Yokoyama, Emi, Ebata, Ko, Matsuoka, Satomi, Hill, Geoffrey R., Sugita, Junichi, Onozawa, Masahiro and Teshima, Takanori (2018). Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease. Blood, 131 (18), 2074-2085. doi: 10.1182/blood-2017-06-792614

Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease

2018

Journal Article

Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset

Hülsdünker, Jan, Ottmüller, Katja J., Neeff, Hannes P., Koyama, Motoko, Gao, Zhan, Thomas, Oliver S., Follo, Marie, Al-Ahmad, Ali, Prinz, Gabriele, Duquesne, Sandra, Dierbach, Heide, Kirschnek, Susanne, Lämmermann, Tim, Blaser, Martin J., Fife, Brian T., Blazar, Bruce R., Beilhack, Andreas, Hill, Geoffrey R., Häcker, Georg and Zeiser, Robert (2018). Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset. Blood, 131 (16), 1858-1869. doi: 10.1182/blood-2017-10-812891

Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset

2018

Journal Article

Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Mathew, Nimitha R, Baumgartner, Francis, Braun, Lukas, O'Sullivan, David, Thomas, Simone, Waterhouse, Miguel, Müller, Tony A, Hanke, Kathrin, Taromi, Sanaz, Apostolova, Petya, Illert, Anna L, Melchinger, Wolfgang, Duquesne, Sandra, Schmitt-Graeff, Annette, Osswald, Lena, Yan, Kai-Li, Weber, Arnim, Tugues, Sonia, Spath, Sabine, Pfeifer, Dietmar, Follo, Marie, Claus, Rainer, Lübbert, Michael, Rummelt, Christoph, Bertz, Hartmut, Wäsch, Ralph, Haag, Johanna, Schmidts, Andrea, Schultheiss, Michael ... Zeiser, Robert (2018). Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature Medicine, 24 (4), 526-526. doi: 10.1038/nm0418-526c

Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

2018

Journal Article

Recipient mucosal-associated invariant T cells control GVHD within the colon

Varelias, Antiopi, Bunting, Mark D., Ormerod, Kate L., Koyama, Motoko, Olver, Stuart D., Straube, Jasmin, Kuns, Rachel D., Robb, Renee J., Henden, Andrea S., Cooper, Leanne, Lachner, Nancy, Gartlan, Kate H., Lantz, Olivier, Kjer-Nielsen, Lars, Mak, Jeffrey Y. W., Fairlie, David P., Clouston, Andrew D., McCluskey, James, Rossjohn, Jamie, Lane, Steven W., Hugenholtz, Philip and Hill, Geoffrey R. (2018). Recipient mucosal-associated invariant T cells control GVHD within the colon. Journal of Clinical Investigation, 128 (5), 1919-1936. doi: 10.1172/JCI91646

Recipient mucosal-associated invariant T cells control GVHD within the colon

2018

Journal Article

Granulocytes are unresponsive to IL-6 due to an absence of gp130

Wilkinson, Andrew N., Gartlan, Kate H., Kelly, Greg, Samson, Luke D., Olver, Stuart D., Avery, Judy, Zomerdijk, Nienke, Tey, Siok-Keen, Lee, Jason S., Vuckovic, Slavica and Hill, Geoffrey R. (2018). Granulocytes are unresponsive to IL-6 due to an absence of gp130. Journal of Immunology, 200 (9), 3547-3555. doi: 10.4049/jimmunol.1701191

Granulocytes are unresponsive to IL-6 due to an absence of gp130

2018

Journal Article

Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients

Hardy, Kristine, Smith, Corey, Tu, Wen Juan, McCuaig, Robert, Panikkar, Archana, Dasari, Vijayendra, Wu, Fan, Tey, Siok-Keen, Hill, Geoffrey R., Khanna, Rajiv and Rao, Sudha (2018). Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients. Blood Advances, 2 (6), 656-668. doi: 10.1182/bloodadvances.2018015909

Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients

2018

Journal Article

Conventional dendritic cells are required for the cross-presentation of leukemia-specific antigen in a model of AML relapse post-BMT

Markey, Kate A., Gartlan, Kate H., Kuns, Rachel D., Lane, Steven W. and Hill, Geoffrey R. (2018). Conventional dendritic cells are required for the cross-presentation of leukemia-specific antigen in a model of AML relapse post-BMT. Bone Marrow Transplantation, 53 (6), 800-803. doi: 10.1038/s41409-018-0148-y

Conventional dendritic cells are required for the cross-presentation of leukemia-specific antigen in a model of AML relapse post-BMT

2018

Journal Article

The impact of age, NPM1, and FLT3 allelic ratio in patients with acute myeloid leukemia

Straube, Jasmin, Ling, Victoria Y, Hill, Geoffrey R and Lane, Steven W (2018). The impact of age, NPM1, and FLT3 allelic ratio in patients with acute myeloid leukemia. Blood, 131 (10), 1148-1153. doi: 10.1182/blood-2017-09-807438

The impact of age, NPM1, and FLT3 allelic ratio in patients with acute myeloid leukemia

2018

Journal Article

Early blood stream infection after BMT is associated with cytokine dysregulation and poor overall survival

Catchpoole, Elizabeth M., Thirunavukarasu, Caitlin E., Varelias, Antiopi, Schlebusch, Sanmarié, Olver, Stuart, Zomerdijk, Nienke, Osland, Emma, Kennedy, Glen A., Tey, Siok-Keen, Hill, Geoffrey R. and Markey, Kate A. (2018). Early blood stream infection after BMT is associated with cytokine dysregulation and poor overall survival. Biology of Blood and Marrow Transplantation, 24 (7), 1360-1366. doi: 10.1016/j.bbmt.2018.02.025

Early blood stream infection after BMT is associated with cytokine dysregulation and poor overall survival

2018

Journal Article

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Mathew, Nimitha R., Baumgartner, Francis, Braun, Lukas, O'Sullivan, David, Thomas, Simone, Waterhouse, Miguel, Müller, Tony A., Hanke, Kathrin, Taromi, Sanaz, Apostolova, Petya, Illert, Anna L., Melchinger, Wolfgang, Duquesne, Sandra, Schmitt-Graeff, Annette, Osswald, Lena, Yan, Kai-Li, Weber, Arnim, Tugues, Sonia, Spath, Sabine, Pfeifer, Dietmar, Follo, Marie, Claus, Rainer, Lübbert, Michael, Rummelt, Christoph, Bertz, Hartmut, Wäsch, Ralph, Haag, Johanna, Schmidts, Andrea, Schultheiss, Michael ... Zeiser, Robert (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature Medicine, 24 (3), 282-291. doi: 10.1038/nm.4484

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

2018

Journal Article

Dysregulated IL-18 Is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment

Nakamura, Kyohei, Kassem, Sahar, Cleynen, Alice, Chrétien, Marie-Lorraine, Guillerey, Camille, Putz, Eva Maria, Bald, Tobias, Förster, Irmgard, Vuckovic, Slavica, Hill, Geoffrey R, Masters, Seth L, Chesi, Marta, Bergsagel, P Leif, Avet-Loiseau, Hervé, Martinet, Ludovic and Smyth, Mark J. (2018). Dysregulated IL-18 Is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment. Cancer Cell, 33 (4), 634-648. doi: 10.1016/j.ccell.2018.02.007

Dysregulated IL-18 Is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment

2018

Journal Article

Atypical chemokine receptor 4 shapes activated B cell fate

Kara, Ervin E., Bastow, Cameron R., McKenzie, Duncan R., Gregor, Carly E., Fenix, Kevin A., Babb, Rachelle, Norton, Todd S., Zotos, Dimitra, Rodda, Lauren B., Hermes, Jana R., Bourne, Katherine, Gilchrist, Derek S., Nibbs, Robert J., Alsharifi, Mohammed, Vinuesa, Carola G., Tarlinton, David M., Brink, Robert, Hill, Geoffrey R., Cyster, Jason G., Comerford, Iain and McColl, Shaun R. (2018). Atypical chemokine receptor 4 shapes activated B cell fate. Journal of Experimental Medicine, 215 (3), 801-813. doi: 10.1084/jem.20171067

Atypical chemokine receptor 4 shapes activated B cell fate